Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Very low fixed-dose versus standard-dose growth hormone replacement in adults with growth hormone deficiency
2009-016783-37Phase 4Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Peripheral insulin sensitivity. Started Oct 2009; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2009-016783-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016783-37.